Beam Therapeutics develops precision medicines through base editing technology to treat genetic diseases.
Business Model:
Revenue: $92M
Employees: 201-500
Address: 26 Landsdowne Street
City: Cambridge
State: MA
Zip: 02139
Country: US
Beam Therapeutics develops precision medicines through base editing technology to treat genetic diseases.
Contact Phone:
+18573278775
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
2/5/2020
IPO Valuation:
$843M
Ticker Symbol:
BEAM
IPO Price:
$17/share
Amount Raised:
$178M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Name | Price |
---|---|---|
2/2021 | Guide Therapeutics |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|